Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers
NCT00861718 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2009-12-10
Summary
Multiple Ascending Dose Study
Conditions
- Healthy
Interventions
- DRUG
-
AZD7268
Capsule, Oral, QD
- DRUG
-
AZD7268
Capsule, Oral, BID
- DRUG
-
Capsule, Oral BID
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Sylvan Hurewitz, M.D. · AstraZeneca Clinical Pharmacology Unit, US
Study Design
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-04-30
- Completion
- 2009-10-31
Countries
- United States
Study Locations
More Related Trials
-
Study to Investigate Multiple Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects
NCT01171105 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects
NCT03435276 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers
NCT01116011 ·Status: COMPLETED ·Phase: PHASE1
-
AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00912353 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers
NCT00754715 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants
NCT06311760 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers
NCT00726427 ·Status: COMPLETED ·Phase: PHASE1
-
AZD5423 Single Ascending Dose Study
NCT00963183 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017
NCT00791752 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects
NCT01247103 ·Status: WITHDRAWN ·Phase: PHASE1
-
Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236
NCT00767052 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers
NCT01051505 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants
NCT06138795 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study
NCT00755378 ·Status: COMPLETED ·Phase: PHASE1
-
AZD2624 Multiple Ascending Dose Study in Japan
NCT00696865 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of AZD8566.
NCT00844103 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AZD4205 in Healthy Adult Subjects
NCT03728023 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Volunteers
NCT00977626 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446
NCT00902993 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy Participants
NCT06122714 ·Status: COMPLETED ·Phase: PHASE1
-
This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects
NCT01030224 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers
NCT00940212 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants
NCT06555822 ·Status: COMPLETED ·Phase: PHASE1
-
AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects
NCT00769899 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy Volunteers
NCT01037725 ·Status: COMPLETED ·Phase: PHASE1